相关实验视频
Updated: Jun 15, 2025
08:22
A Preclinical Model of Exertional Heat Stroke in Mice
Published on: July 1, 2021
3.7K
通过暴露于热量引起心肌梗塞的触发因药物摄入而改变
Kai Chen1,2, Robert Dubrow3,4, Susanne Breitner5,6
1Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA. kai.chen@yale.edu.
Nature cardiovascular research
|August 28, 2024
概括
暴露于热量会增加非致命心肌梗塞 (MI) 的风险,特别是在使用抗血小板药物或β受体抑制剂的患者中. 这种对与热相关的MI的高度脆弱性在年轻人中更为明显.
科学领域:
- 心脏病学 心脏病学
- 环境健康 环境健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 暴露于热量是急性心肌梗塞 (MI) 的已知触发因素.
- 使用心血管药物的患者对与热有关的MI的特定脆弱性尚不清楚.
- 以前存在的冠心病 (CHD) 可能会影响心脏病发作风险并混药物效应.
研究的目的:
- 调查心血管药物是否会改变与热相关的非致命心肌梗塞的风险.
- 检查因年龄和先前存在的冠状动脉心脏病 (CHD) 的效果修饰.
主要方法:
- 在德国奥格斯堡 (2001-2014) 在温暖的季节 (五月到九月) 分析了2,494例心脏病发病例.
- 对抗血小板药物和β受体抑制剂的使用者和非使用者之间的与热有关的非致命性心脏病发作风险的比较.
- 根据年龄组 (25-59岁和60-74岁) 的分析分层和心脏病发病率.
主要成果:
- 与非使用者相比,使用抗血小板药物和β受体抑制剂的患者中,与热相关的非致命性心脏病发作风险显著增加.
- 这种药物效应的改变在年轻患者 (25-59岁) 中更强,心脏病发病率较低.
- 老年患者 (60-74岁) 患心血管疾病的患病率较高,可能会混观察到的药物效应.
结论:
- 使用抗血小板药物或β受体抑制剂的患者可能面临与热相关的非致命性心脏病发作的脆弱性增加.
- 在这种关系中,年龄和潜在的冠状动脉疾病患病率是需要考虑的重要因素.
- 需要进一步的研究,以区分药物使用与先前存在的CHD在与热有关的MI风险中的影响.
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
547
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
547
01:20Exercise and Cardiovascular Response
750
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
750
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
01:25Increased Body Temperature
647
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
647
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K